Literature DB >> 9098288

Risk factors for cotton-wool spots and for cytomegalovirus retinitis in patients with human immunodeficiency virus infection.

R F Spaide1, A Gaissinger, J R Podhorzer.   

Abstract

PURPOSE: To investigate the risk factors for cotton-wool spots and for cytomegalovirus retinitis in patients with human immunodeficiency virus infection (HIV).
METHODS: A cross-sectional study was performed on 453 consecutive male patients with a positive serodiagnosis for HIV. The possible risk factors of age, race, absolute T-lymphocyte CD4+ count, and mode of HIV acquisition were evaluated.
RESULTS: Age and race were not significant predictors of either cotton-wool spots or cytomegalovirus retinitis. Low CD4+ T-lymphocyte counts were the strongest predictor of both types of retinopathy. After adjustment for CD4+ T-lymphocyte counts by logistic regression, patients who had acquired HIV through homosexual or bisexual activity were more likely to have cotton-wool spots (odds ratio, 2.09; P = 0.029) and cytomegalovirus retinitis (odds ratio, 4.14; P = 0.0028) than were patients who had acquired the disease intravenously.
CONCLUSIONS: The results of this study showed that the ocular manifestations of HIV infection are associated with low CD4+ counts and HIV acquisition through bisexual or homosexual activity. Patients with these risks factors should be targeted for prophylaxis and prevention strategies for cytomegalovirus retinitis.

Entities:  

Mesh:

Year:  1995        PMID: 9098288     DOI: 10.1016/s0161-6420(95)30783-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Human immunodeficiency virus-related retinal microangiopathy and systemic cytomegalovirus disease association.

Authors:  Yuko Iwasaki; Narumichi Yamamoto; Tatsushi Kawaguchi; Noriko Ozaki; Makoto Tomita; Atsushi Ajisawa; Manabu Mochizuki; Kimio Murakami
Journal:  Jpn J Ophthalmol       Date:  2013-05-23       Impact factor: 2.447

2.  [Tropical ophthalmology--prevention and therapy"Vision 2020--the right to sight"].

Authors:  V Klauss; U C Schaller
Journal:  Ophthalmologe       Date:  2004-06-16       Impact factor: 1.059

3.  Post-CD19 Chimeric Antigen Receptor T-Cell Therapy Cytomegalovirus Retinitis.

Authors:  Haifa Bin Dokhi; Amjad O Alharbi; Nida H Ibnouf; Bader Alahmari; Mohammed N Refka
Journal:  Cureus       Date:  2022-03-09

Review 4.  Cytomegalovirus Retinitis in HIV and Non-HIV Individuals.

Authors:  Monique Munro; Tejabhiram Yadavalli; Cheryl Fonteh; Safa Arfeen; Ann-Marie Lobo-Chan
Journal:  Microorganisms       Date:  2019-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.